These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 33811536

  • 1. A novel NECTIN4-NTRK1 fusion identified in a lung squamous cell carcinoma patient with MSI-H.
    Li P, Hou F, Wang S, Luo N, Qi Y, Wang Y.
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2483-2486. PubMed ID: 33811536
    [No Abstract] [Full Text] [Related]

  • 2. EPS15-NTRK1: a novel NTRK1 oncogenic fusion in patient with lung adenocarcinoma.
    Yang S, Li L, Chen D, Xiao M, Xian L.
    J Cancer Res Clin Oncol; 2020 Dec; 146(12):3389-3392. PubMed ID: 33037466
    [No Abstract] [Full Text] [Related]

  • 3. Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer.
    Vaishnavi A, Capelletti M, Le AT, Kako S, Butaney M, Ercan D, Mahale S, Davies KD, Aisner DL, Pilling AB, Berge EM, Kim J, Sasaki H, Park S, Kryukov G, Garraway LA, Hammerman PS, Haas J, Andrews SW, Lipson D, Stephens PJ, Miller VA, Varella-Garcia M, Jänne PA, Doebele RC.
    Nat Med; 2013 Nov; 19(11):1469-1472. PubMed ID: 24162815
    [Abstract] [Full Text] [Related]

  • 4. NTRK1 fusions for the therapeutic intervention of Korean patients with colon cancer.
    Park DY, Choi C, Shin E, Lee JH, Kwon CH, Jo HJ, Kim HR, Kim HS, Oh N, Lee JS, Park OK, Park E, Park J, Shin JY, Kim JI, Seo JS, Park HD, Park J.
    Oncotarget; 2016 Feb 16; 7(7):8399-412. PubMed ID: 26716414
    [Abstract] [Full Text] [Related]

  • 5. Evidence of NTRK1 Fusion as Resistance Mechanism to EGFR TKI in EGFR+ NSCLC: Results From a Large-Scale Survey of NTRK1 Fusions in Chinese Patients With Lung Cancer.
    Xia H, Xue X, Ding H, Ou Q, Wu X, Nagasaka M, Shao YW, Hu X, Ou SI.
    Clin Lung Cancer; 2020 May 16; 21(3):247-254. PubMed ID: 31761448
    [Abstract] [Full Text] [Related]

  • 6. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.
    Prasad ML, Vyas M, Horne MJ, Virk RK, Morotti R, Liu Z, Tallini G, Nikiforova MN, Christison-Lagay ER, Udelsman R, Dinauer CA, Nikiforov YE.
    Cancer; 2016 Apr 01; 122(7):1097-107. PubMed ID: 26784937
    [Abstract] [Full Text] [Related]

  • 7. ALK, ROS1 and RET rearrangements in lung squamous cell carcinoma are very rare.
    Zhao W, Choi YL, Song JY, Zhu Y, Xu Q, Zhang F, Jiang L, Cheng J, Zheng G, Mao M.
    Lung Cancer; 2016 Apr 01; 94():22-7. PubMed ID: 26973202
    [Abstract] [Full Text] [Related]

  • 8. A Comparison of Morphologic and Molecular Features of BRAF, ALK, and NTRK1 Fusion Spitzoid Neoplasms.
    Amin SM, Haugh AM, Lee CY, Zhang B, Bubley JA, Merkel EA, Verzì AE, Gerami P.
    Am J Surg Pathol; 2017 Apr 01; 41(4):491-498. PubMed ID: 27776007
    [Abstract] [Full Text] [Related]

  • 9. A novel KLHL6/KLHL24 intergenic region-NTRK3 fusion in a patient with lung squamous cell carcinoma.
    Zhao D, Hou F, Li M, Qi Y, Luo N, Wang Y.
    Lung Cancer; 2021 May 01; 155():193-195. PubMed ID: 33744021
    [No Abstract] [Full Text] [Related]

  • 10. Identification of recurrent FGFR3 fusion genes in lung cancer through kinome-centred RNA sequencing.
    Majewski IJ, Mittempergher L, Davidson NM, Bosma A, Willems SM, Horlings HM, de Rink I, Greger L, Hooijer GK, Peters D, Nederlof PM, Hofland I, de Jong J, Wesseling J, Kluin RJ, Brugman W, Kerkhoven R, Nieboer F, Roepman P, Broeks A, Muley TR, Jassem J, Niklinski J, van Zandwijk N, Brazma A, Oshlack A, van den Heuvel M, Bernards R.
    J Pathol; 2013 Jul 01; 230(3):270-6. PubMed ID: 23661334
    [Abstract] [Full Text] [Related]

  • 11. The first report of molecular characterized BRD4-NUT carcinoma in Brazil: a case report.
    Oliveira LJC, Gongora ABL, Latancia MT, Barbosa FG, Gregorio JVAM, Testagrossa LA, Amano MT, Feher O.
    J Med Case Rep; 2019 Sep 07; 13(1):279. PubMed ID: 31492174
    [Abstract] [Full Text] [Related]

  • 12. LMNA::NTRK1 Fusion-positive Leiomyosarcoma: Discrepancy between DNA-based Comprehensive Genomic Profiling and RNA Sequencing.
    Suzuki N, Idogawa M, Emori M, Murase K, Arihara Y, Nakamura H, Usami M, Kubo T, Kinoshita I, Sugita S, Tokino T, Hasegawa T, Sakurai A, Takada K.
    Intern Med; 2024 Aug 01; 63(15):2215-2219. PubMed ID: 38104989
    [Abstract] [Full Text] [Related]

  • 13. Microsatellite instability at chromosome 8p in non-small cell lung cancer is associated with lymph node metastasis and squamous differentiation.
    Woenckhaus M, Stoehr R, Dietmaier W, Wild PJ, Zieglmeier U, Foerster J, Merk J, Blaszyk H, Pfeifer M, Hofstaedter F, Hartmann A.
    Int J Oncol; 2003 Nov 01; 23(5):1357-63. PubMed ID: 14532977
    [Abstract] [Full Text] [Related]

  • 14. Durable Clinical Response to Crizotinib in IRF2BP2-NTRK1 Non-small-cell Lung Cancer.
    Wang B, Gao Y, Huang Y, Ou Q, Fang T, Tang C, Wu X, Shao YW.
    Clin Lung Cancer; 2019 May 01; 20(3):e233-e237. PubMed ID: 30691963
    [No Abstract] [Full Text] [Related]

  • 15. Identifying patients with NTRK fusion cancer.
    Solomon JP, Benayed R, Hechtman JF, Ladanyi M.
    Ann Oncol; 2019 Nov 01; 30 Suppl 8():viii16-viii22. PubMed ID: 32223934
    [Abstract] [Full Text] [Related]

  • 16. STRN3-NTRK1: A Novel NTRK1 Oncogenic Fusion in a Patient with Lung Adenocarcinoma.
    Lu R, Qi C, Xiao M, Cai S, Zheng M.
    J Thorac Oncol; 2020 Feb 01; 15(2):e23-e24. PubMed ID: 32127185
    [No Abstract] [Full Text] [Related]

  • 17. Mammalian mastermind like 2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma.
    Achcar Rde O, Nikiforova MN, Dacic S, Nicholson AG, Yousem SA.
    Hum Pathol; 2009 Jun 01; 40(6):854-60. PubMed ID: 19269006
    [Abstract] [Full Text] [Related]

  • 18. Paediatric and adult soft tissue sarcomas with NTRK1 gene fusions: a subset of spindle cell sarcomas unified by a prominent myopericytic/haemangiopericytic pattern.
    Haller F, Knopf J, Ackermann A, Bieg M, Kleinheinz K, Schlesner M, Moskalev EA, Will R, Satir AA, Abdelmagid IE, Giedl J, Carbon R, Rompel O, Hartmann A, Wiemann S, Metzler M, Agaimy A.
    J Pathol; 2016 Apr 01; 238(5):700-10. PubMed ID: 26863915
    [Abstract] [Full Text] [Related]

  • 19. A study of ALK-positive pulmonary squamous-cell carcinoma: From diagnostic methodologies to clinical efficacy.
    Wang H, Sun L, Sang Y, Yang X, Tian G, Wang Z, Fang J, Sun W, Zhou L, Jia L, Tsao MS, Shi H, Lin D.
    Lung Cancer; 2019 Apr 01; 130():135-142. PubMed ID: 30885334
    [Abstract] [Full Text] [Related]

  • 20. Next-generation sequencing informs diagnosis and identifies unexpected therapeutic targets in lung squamous cell carcinomas.
    Sands JM, Nguyen T, Shivdasani P, Sacher AG, Cheng ML, Alden RS, Jänne PA, Kuo FC, Oxnard GR, Sholl LM.
    Lung Cancer; 2020 Feb 01; 140():35-41. PubMed ID: 31855703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.